Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$155.22 - $162.74 $198,526 - $208,144
1,279 New
1,279 $202,000
Q2 2023

Aug 01, 2023

BUY
$154.35 - $166.11 $193,246 - $207,969
1,252 New
1,252 $207,000
Q4 2022

Feb 15, 2023

BUY
$160.2 - $179.79 $10,252 - $11,506
64 Added 3.12%
2,117 $373,000
Q3 2022

Oct 26, 2022

BUY
$161.33 - $179.52 $1,290 - $1,436
8 Added 0.39%
2,053 $335,000
Q2 2022

Aug 16, 2022

BUY
$168.19 - $186.01 $1,177 - $1,302
7 Added 0.34%
2,045 $363,000
Q1 2022

Apr 29, 2022

BUY
$158.14 - $179.59 $1,265 - $1,436
8 Added 0.39%
2,038 $361,000
Q4 2021

Mar 02, 2022

BUY
$155.93 - $173.01 $1,091 - $1,211
7 Added 0.35%
2,030 $347,000
Q3 2021

Dec 09, 2021

BUY
$161.5 - $179.47 $326,714 - $363,067
2,023 New
2,023 $327,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Fidelis I M, LLC Portfolio

Follow Fidelis I M, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fidelis I M, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fidelis I M, LLC with notifications on news.